Position in ALXO
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,158,454
+$557,470 QoQ
Shares Held
577,783
+8.6% QoQ
Ownership
0.429%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. ALXO ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,158,454 | 577,783 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $600,984 | 531,845 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $971,414 | 530,828 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $429,577 | 1,035,127 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $904,456 | 1,451,778 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,728,994 | 1,035,326 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $317,813 | 174,623 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $247,290 | 41,010 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $525,777 | 47,155 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $964,216 | 64,756 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $248,389 | 51,748 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $205,030 | 27,301 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $114,830 | 25,405 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,288,643 | 203,074 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $212,510 | 22,206 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $136,509 | 16,874 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $991,708 | 58,681 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,489,794 | 69,325 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $510,074 | 6,906 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $322,993 | 5,907 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $234,123 | 3,175 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $612,881 | 7,110 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $321,166 | 8,510 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||